Mitsubishi Chemical Gloup CorporationJP:4188Stock Price

Market cap
¥1.37T
P/E ratio
26.6x
Mitsubishi Chemical Group manufactures chemicals, specialty materials, pharmaceuticals, and industrial gases across five major business segments serving industries worldwide.

Price and Volume

Market Cap

Subscribe to premium to access
Market Cap.

Check pricing

PER

Subscribe to premium to access
PER.

Check pricing

PBR

Business Overview

Mitsubishi Chemical Group operates five major business segments, each offering diverse products and services. These segments are Specialty Materials, MMA & Derivatives, Basic Materials & Polymers, Pharma, and Industrial Gases.

The Specialty Materials segment provides high-performance materials and products, particularly in electronic materials and advanced plastics. It plays a critical role in supporting cutting-edge technologies.

The MMA & Derivatives segment manufactures and sells methyl methacrylate (MMA), acrylic resins, and related products. These materials are used across a wide range of applications, including automotive and construction.

The Basic Materials & Polymers segment supplies basic chemicals and polymer products. It provides the foundation for many essential products used in everyday life.

The Pharma segment focuses on pharmaceutical research, development, and manufacturing. Its activities in generic drugs and biopharmaceuticals are particularly noteworthy.

The Industrial Gases segment manufactures and supplies industrial gases, serving a critical role across various industries. It contributes to improving manufacturing efficiency and safety.

Management Policy

Mitsubishi Chemical Group announced "KAITEKI Vision 35" and "New Medium-Term Management Plan 2029" in November 2024. This vision aims to become a "Green Specialty Company" by 2035, continuing to provide optimal solutions to social challenges. The company is pursuing a dual strategy of realizing KAITEKI while achieving sustainable corporate growth.

The company has identified five priority business areas. These include a stable supply foundation for green chemicals, environmentally conscious mobility, advanced data processing and communications, food quality preservation, and technologies and equipment required for new therapeutic treatments. The company seeks to enhance corporate value through growth in these areas.

As part of its growth strategy, the company is prioritizing the turnaround of its chemicals business. Under "New Medium-Term Management Plan 2029," the company will establish selection criteria and disciplined business operation principles to pursue portfolio transformation and profit improvement. It will advance the reorganization and divestiture of non-core businesses while expanding core operating profit.

The company is also promoting the sharing of technologies and expertise across organizational and business boundaries, using "connection" as a key concept. This aims to accelerate innovation through fresh ideas and enable rapid responses to social challenges. Through strategic partnerships, the company will deliver optimal solutions.

Additionally, the company is strengthening safety management and compliance, ensuring proper operation of internal control systems, and enhancing group governance. These efforts will reinforce the foundation for sustainable corporate growth and improve corporate value and shareholder value.